Join to View Full Profile
6525 Drew Ave SEdina, MN 55435
Phone+1 952-920-6748
Fax+1 952-920-3863
Dr. Adson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Adson is a psychiatrist based in Edina, MN. He completed his medical degree at the University of Minnesota Medical School in 1980 and his psychiatry residency there from 1993 to 1996. Prior to that, he undertook residencies in surgery and orthopaedic surgery. Dr. Adson has contributed to the field through multiple research publications on various psychiatric topics, including treatment-resistant depression and major depressive disorder. His most cited work involves aripiprazole augmentation in depression, with 196 citations. Additionally, he has been involved in clinical trials, such as exploring the use of quetiapine in treating social phobia. Dr. Adson has received CMS Meaningful Use certifications from Epic Systems Corporation for adherence to electronic health record standards.
Education & Training
University of MinnesotaResidency, Psychiatry, 1993 - 1996
Emory University School of MedicineResidency, Orthopaedic Surgery, 1982 - 1983
Morehouse School of MedicineResidency, Surgery, 1980 - 1981- University of Minnesota Medical SchoolClass of 1980
Certifications & Licensure
MN State Medical License 1983 - 2027
GA State Medical License 1981 - 1987
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2015-2016
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment Start of enrollment: 2006 Dec 01
Publications & Presentations
PubMed
- A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination.José V Pardo, Sohail A Sheikh, Graeme Schwindt, Joel T Lee, David E Adson
PloS one. 2020-01-14 - 5 citationsA preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination.José V. Pardo, Sohail A. Sheikh, Graeme Schwindt, Joel T. Lee, David E. Adson
Plos One. 2020-01-13 - 8 citationsEffect of Paroxetine on Physiological Response to Stress and SmokingMichael Kotlyar, Mustafa al'Absi, Paul Thuras, John P. Vuchetich, David E. Adson
Psychosomatic Medicine. 2013-03-15
Press Mentions
What A Scathing External Report on Protections in Research Missed -- or IgnoredMarch 11th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
